PCSK9 and familial hyperaldosteronism: Conversely, PCSK9 loss-of-function (PCSK9-LOF) genetic variants in patients with FH may lead to unusual responses to PCSK9-mAbs because of the low relative efficacy of PCSK9 in circulation (52).